220 related articles for article (PubMed ID: 18480695)
1. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
[No Abstract] [Full Text] [Related]
2. [Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report].
Díaz-Marsá M; Galian M; Montes A; Fernández R; Arza R; López-Ibor J; Carrasco J
Actas Esp Psiquiatr; 2008; 36(2):70-4. PubMed ID: 18365787
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic treatment in the borderline patient: advantages and techniques.
Soloff PH
J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine in patients with borderline personality disorder: an open-label trial.
Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
[TBL] [Abstract][Full Text] [Related]
5. Risperidone in anorexia nervosa.
Newman-Toker J
J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941-2. PubMed ID: 10939220
[No Abstract] [Full Text] [Related]
6. [Borderline personality disorder and transsexualism].
Seikowski K; Gollek S; Harth W; Reinhardt M
Psychiatr Prax; 2008 Apr; 35(3):135-41. PubMed ID: 17671917
[TBL] [Abstract][Full Text] [Related]
7. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
8. Risperidone in comorbid borderline personality disorder and dysthymia.
Szigethy EM; Schulz SC
J Clin Psychopharmacol; 1997 Aug; 17(4):326-7. PubMed ID: 9241018
[No Abstract] [Full Text] [Related]
9. Planning in borderline personality disorder: evidence for distinct subpopulations.
Bustamante ML; Villarroel J; Francesetti V; Ríos M; Arcos-Burgos M; Jerez S; Iturra P; Solari A; Silva H
World J Biol Psychiatry; 2009; 10(4 Pt 2):512-7. PubMed ID: 19658046
[TBL] [Abstract][Full Text] [Related]
10. Personality trait interactions in parents of patients with borderline personality disorder: a controlled study using the Temperament and Character Inventory.
Fassino S; Amianto F; Gastaldi F; Abbate-Daga G; Brambilla F; Leombruni P
Psychiatry Res; 2009 Jan; 165(1-2):128-36. PubMed ID: 19081640
[TBL] [Abstract][Full Text] [Related]
11. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.
Kutcher S; Papatheodorou G; Reiter S; Gardner D
J Psychiatry Neurosci; 1995 Mar; 20(2):113-8. PubMed ID: 7703220
[TBL] [Abstract][Full Text] [Related]
12. Emotion processing in borderline personality disorders.
Bland AR; Williams CA; Scharer K; Manning S
Issues Ment Health Nurs; 2004; 25(7):655-72. PubMed ID: 15371135
[TBL] [Abstract][Full Text] [Related]
13. Risperidone treatment of an adolescent with severe posttraumatic stress disorder.
Keeshin BR; Strawn JR
Ann Pharmacother; 2009 Jul; 43(7):1374. PubMed ID: 19584378
[No Abstract] [Full Text] [Related]
14. Psychopharmacology of borderline personality disorder: a review.
Cowdry RW
J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients.
Sansone RA; Schumacher D; Wiederman MW; Routsong-Weichers L
Eat Behav; 2008 Apr; 9(2):197-202. PubMed ID: 18329598
[TBL] [Abstract][Full Text] [Related]
16. Impact of borderline personality disorder on bulimia nervosa.
Rowe SL; Jordan J; McIntosh VV; Carter FA; Bulik CM; Joyce PR
Aust N Z J Psychiatry; 2008 Dec; 42(12):1021-9. PubMed ID: 19016090
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-associated steatohepatitis and excessive weight-gain.
Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
[TBL] [Abstract][Full Text] [Related]
18. [Risperidone and edema: apropos of a case].
Masson M; Elayli R; Verdoux H
Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
[No Abstract] [Full Text] [Related]
19. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
[TBL] [Abstract][Full Text] [Related]
20. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
Leitner P; Serfling R
Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
